Introduction Migraine is a disease of the central nervous system characterized by moderate or severe headache. Migraine is considered the third most prevalent disease and the seventh specific cause of incapacity in the world. The prevalence of migraine in women increase after menarche compared with the prevalence of migraine in men. According to previous population-based studies, during reproductive years, a woman who has the diagnosis of menstrual migraine experiences the same symptoms throughout pregnancy and postpartum. Childbirth is a major event in a woman’s life. However, some mothers might present symptoms of postnatal depression. Postpartum depression is a mental disorder that reflects on the maternal role. Thus, it has negative consequences for them and their children. Postpartum depression is associated with increased risk for cognitive BB impairment, emotional difficulties and behavioral problems. Clinically, headache influences the mental and physical health of pregnant and postpartum women. Studies reported that anxiety and depression disorders are two to ten times more common in migraineurs than in the general population. Therefore, it can be a risk for postpartum depression development. Objective To verify postpartum depression in migraine and non-migraine parturients. Methods Data was collected from a sample of 155 women, older than 18 years old, in the obstetric center of Santa Casa de Misericórdia de Barbacena, between October 2021 and August 2022, in the first 24 hours after labor by the members of the research. Clinic and concomitant disorders were collected from the patient's record. Parturients who did not agree to participate in the study and those with cognitive impairment were excluded. All the patients signed an informed consent form to participate in the study. All the patients answered the Edinburgh Postnatal Depression Scale (EPDS) and the ID-Migraine... (To see the complet abstract, please, check out the PDF.)
Introduction Migraine is a frequent and chronic condition that affects 3 times more women than men. Overall, it shows that migraine is influenced by variables such as fluctuating hormones levels throughout life with migraine. Women can also experience symptoms of postpartum depression (PPD) which can cause issues for new moms in terms of behavior, emotion and cognition. Clinical investigations have shown that headaches affects pregnants and parturients. Objective To verify PPD in migraine and non-migrainous parturients. Methods Data was collected from a sample of 155 women over 18 years old in the obstetric center of Santa Casa de Misericórdia de Barbacena, from October 2021 to August 2022, in the first 24 hours after labor. Parturients who did not agree to participate and those with cognitive impairment were excluded. All patients signed an informed consent form and answered the Edinburgh Postnatal Depression Scale (EPDS) and the ID-MigraineTM, in addition to clinic data and concomitant disorders from the patient's record. Results 25 of the 155 postpartum women achieved the criteria for migraine and 130 for non-migraine. Of the patients with postpartum depression associated with migraine, 4 were classified as migraine and 8 as non-migrainous. Among patients who had headaches during pregnancy, 11 had PPD compared to those who did not have headaches during pregnancy: 1. The OR=8.9 (CI 1.12-70) and RR=7.9 (CI 1.05-60) were higher compared to those who did not have PPD. The analysis did not find a relation between migraine and PPD. However, a relation was found between headaches during pregnancy and the presence of PPD (p<0.05). Conclusion Patients who experienced headaches while pregnant are more likely to have postpartum depression. However, migraine-diagnosed puerperal women do not present considerable concerns for the development of depression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.